Patent · US Active

EP2 and EP4 agonists as agents for the treatment of influenza a viral infection

US8980944B2 · kind B2 · utility

1Cited by

13References

8Claims

0Family size

Assignee

Gemmus Pharma Inc. · US

Inventors

Daryl Faulds · Mill Valley, US
William Guilford · San Leandro, US
Wolfgang Seifert · Wielenbach, DE

Key dates

Filing date	Mar 28, 2011
Grant date	Mar 17, 2015
Priority date	—
Expiry date	Sep 9, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/343
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to the use of EP2 and/or EP4 agonists as therapeutics for the treatment of diseases associated with influenza A viruses, such as for example H5N1 and mutations thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.